IL6 and Cognitive impairment: When exploring differences in blood biomarkers between PCC groups stratified according to cognitive impairment, higher levels of interleukin 6 and lower levels of D-dimer were found in cognitively altered PCC participants, compared with non-cognitively altered PCC.